Fri, Oct 25, 2019 · 10:00

On behalf of the University of Cincinnati and CURRENT PSYCHIATRY, we invite you to attend the 17th Annual Psychopharmacology Update.
At this CME symposium, nationally renowned faculty will discuss Recent Breakthroughs in Psychopharmacology: Novel Treatments
Topics Include:
Long-Acting Injectables for Psychotic and Mood Disorders
Emergence of Hallucinogens as Novel Treatments for Depression, Anxiety and PTSD
Breakthrough Treatment for Postpartum Depression
Pharmacotherapy for Tardive Dyskinesia in Mood and Psychotic Disorders
Treatment for Clozapine-Resistant Psychosis
Treating Parkinson's Disease Psychosis with a Non-Dopaminergic Agent
Esketamine for Treatment-Resistant Depression

New for 2019 we are offering optional, pre-conference Addiction and Medical Cannabis Workshops on Friday, October 25. Workshops have limited space available. First come. First served!

Directed by Henry Nasrallah, MD, Professor and Chairman, Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, this well-established CME symposium offers an outstanding opportunity for education and networking with minimal disruption to your busy schedule. You will get in-depth analysis from our expert faculty and ample time to query them on topics that will help keep your practice ahead of the curve. 11.5 CME credits available.

Discount room rates available at our host venue, the Kingsgate Hotel Conference Center in Cincinnati.

Sponsor and exhibit opportunities available.

Early Bird until Aug 12: USD 175.0,
Discount Rate Sept 23: USD 225.0,
Standard Rate : USD 325.0

Speakers: Henry A. Nasrallah, MD, Leslie Citrome, MD, MPH , Alberto J. Espay, MD, MSc, James W. Murrough, MD, PhD, Ruta M. Nonacs, MD, PhD, Andrew Penn, MS, NP, PMHNP-BC